Cargando…

Clostridium difficile Infection in Special High-Risk Populations

Antibiotic use continues to be the most important risk factor for the development of Clostridium difficile infection (CDI) through disruption of the indigenous microbiota of the colon. This factor, together with environmental contamination, makes hospital and other healthcare facilities the perfect...

Descripción completa

Detalles Bibliográficos
Autores principales: Cózar-Llistó, Alberto, Ramos-Martinez, Antonio, Cobo, Javier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019980/
https://www.ncbi.nlm.nih.gov/pubmed/27515721
http://dx.doi.org/10.1007/s40121-016-0124-z
_version_ 1782453152381927424
author Cózar-Llistó, Alberto
Ramos-Martinez, Antonio
Cobo, Javier
author_facet Cózar-Llistó, Alberto
Ramos-Martinez, Antonio
Cobo, Javier
author_sort Cózar-Llistó, Alberto
collection PubMed
description Antibiotic use continues to be the most important risk factor for the development of Clostridium difficile infection (CDI) through disruption of the indigenous microbiota of the colon. This factor, together with environmental contamination, makes hospital and other healthcare facilities the perfect breeding ground for the infection. Several groups of patients are exposed to the hospital environment and, at the same time, affected by conditions that can make CDI more prevalent, more severe or make it present a different clinical picture. The list of such conditions appears too extensive to be reviewed in a single article. Nevertheless, several groups, including the critically ill, oncological patients, solid organ and hematopoietic transplant recipients, patients with inflammatory bowel disease, patients with kidney disease and pregnant women, have generated more attention and have been studied in more detail. On the other hand, pediatric patients constitute a controversial group because the large number of asymptomatic carriers makes interpretation of clinical findings and diagnostic tests difficult, as is the development of an appropriate approach to treatment. We present an in-depth discussion of CDI in these high-risk populations and we also review the issue of CDI in pediatric patients.
format Online
Article
Text
id pubmed-5019980
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Springer Healthcare
record_format MEDLINE/PubMed
spelling pubmed-50199802016-09-26 Clostridium difficile Infection in Special High-Risk Populations Cózar-Llistó, Alberto Ramos-Martinez, Antonio Cobo, Javier Infect Dis Ther Review Antibiotic use continues to be the most important risk factor for the development of Clostridium difficile infection (CDI) through disruption of the indigenous microbiota of the colon. This factor, together with environmental contamination, makes hospital and other healthcare facilities the perfect breeding ground for the infection. Several groups of patients are exposed to the hospital environment and, at the same time, affected by conditions that can make CDI more prevalent, more severe or make it present a different clinical picture. The list of such conditions appears too extensive to be reviewed in a single article. Nevertheless, several groups, including the critically ill, oncological patients, solid organ and hematopoietic transplant recipients, patients with inflammatory bowel disease, patients with kidney disease and pregnant women, have generated more attention and have been studied in more detail. On the other hand, pediatric patients constitute a controversial group because the large number of asymptomatic carriers makes interpretation of clinical findings and diagnostic tests difficult, as is the development of an appropriate approach to treatment. We present an in-depth discussion of CDI in these high-risk populations and we also review the issue of CDI in pediatric patients. Springer Healthcare 2016-08-11 2016-09 /pmc/articles/PMC5019980/ /pubmed/27515721 http://dx.doi.org/10.1007/s40121-016-0124-z Text en © The Author(s) 2016 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Review
Cózar-Llistó, Alberto
Ramos-Martinez, Antonio
Cobo, Javier
Clostridium difficile Infection in Special High-Risk Populations
title Clostridium difficile Infection in Special High-Risk Populations
title_full Clostridium difficile Infection in Special High-Risk Populations
title_fullStr Clostridium difficile Infection in Special High-Risk Populations
title_full_unstemmed Clostridium difficile Infection in Special High-Risk Populations
title_short Clostridium difficile Infection in Special High-Risk Populations
title_sort clostridium difficile infection in special high-risk populations
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5019980/
https://www.ncbi.nlm.nih.gov/pubmed/27515721
http://dx.doi.org/10.1007/s40121-016-0124-z
work_keys_str_mv AT cozarllistoalberto clostridiumdifficileinfectioninspecialhighriskpopulations
AT ramosmartinezantonio clostridiumdifficileinfectioninspecialhighriskpopulations
AT cobojavier clostridiumdifficileinfectioninspecialhighriskpopulations